Entero Therapeutics Inc (ENTO)
2.74
+0.11
(+4.18%)
USD |
NASDAQ |
May 31, 16:00
2.75
+0.01
(+0.36%)
After-Hours: 20:00
Entero Therapeutics Accounts Payable (Quarterly): 1.996M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.996M |
| December 31, 2023 | 0.5543M |
| September 30, 2023 | 0.5793M |
| June 30, 2023 | 1.591M |
| March 31, 2023 | 0.4698M |
| December 31, 2022 | 0.72M |
| September 30, 2022 | 3.583M |
| June 30, 2022 | 3.966M |
| March 31, 2022 | 3.450M |
| December 31, 2021 | 2.708M |
| September 30, 2021 | 18.45M |
| June 30, 2021 | 4.450M |
| March 31, 2021 | 1.441M |
| December 31, 2020 | 1.559M |
| September 30, 2020 | 1.460M |
| June 30, 2020 | 1.597M |
| March 31, 2020 | 1.322M |
| Date | Value |
|---|---|
| December 31, 2019 | 2.217M |
| September 30, 2019 | 2.710M |
| June 30, 2019 | 2.798M |
| March 31, 2019 | 2.887M |
| December 31, 2018 | 2.202M |
| September 30, 2018 | 1.144M |
| June 30, 2018 | 1.489M |
| March 31, 2018 | 1.382M |
| December 31, 2017 | 1.573M |
| September 30, 2017 | 1.288M |
| June 30, 2017 | 0.773M |
| March 31, 2017 | 1.342M |
| December 31, 2016 | 1.072M |
| September 30, 2016 | 1.486M |
| June 30, 2016 | 1.270M |
| March 31, 2016 | 0.9166M |
| December 31, 2015 | 0.4094M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.4698M
Minimum
Mar 2023
18.45M
Maximum
Sep 2021
2.881M
Average
1.797M
Median
Accounts Payable (Quarterly) Benchmarks
| BioVie Inc | -- |
| Jaguar Health Inc | 3.32M |
| Benitec Biopharma Inc | 0.815M |
| Immuneering Corp | 2.271M |
| NovaBay Pharmaceuticals Inc | 1.117M |